Quarterly report [Sections 13 or 15(d)]

Note 13 - Stock-based Compensation (Tables)

v3.25.1
Note 13 - Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Notes To Financial Statements [Abstract]  
Share-based Payment Arrangement, Option, Activity

Stock option transactions for the three months ended March 31, 2025 and 2024 are summarized as follows:

 

 

 

 

 

 

Three months ended
March 31, 2025

 

 

 

 

 

 

Options

 

 

Weighted average
exercise price

 

 

Weighted average remaining contractual life
(years)

 

Outstanding, beginning of period

 

 

39,489

 

 

$

1,170.30

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(753

)

 

 

1,400.00

 

 

 

 

Outstanding, end of the period

 

 

38,736

 

 

$

1,166.33

 

 

 

6.3

 

Exercisable, end of the period

 

 

30,593

 

 

$

1,415.22

 

 

 

5.8

 

Vested and expected to vest, end of period

 

 

36,728

 

 

$

1,218.08

 

 

 

6.2

 

 

 

 

 

 

 

Three months ended
March 31, 2024

 

 

 

 

 

 

Options

 

 

Weighted average
exercise price

 

 

Weighted average remaining contractual life
(years)

 

Outstanding, beginning of period

 

 

39,464

 

 

$

1,343.40

 

 

 

 

Granted

 

 

13,605

 

 

 

60.00

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(2,915

)

 

 

343.80

 

 

 

 

Outstanding, end of the period

 

 

50,154

 

 

$

1,049.40

 

 

 

7.04

 

Exercisable, end of the period

 

 

29,862

 

 

$

1,602.30

 

 

 

5.56

 

Vested and expected to vest, end of period

 

 

44,662

 

 

$

1,102.80

 

 

 

7.03

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following table presents the weighted average assumptions that were used in the Black‑Scholes option pricing model to determine the fair value of stock options granted during the period and the resulting weighted-average fair values:

 

 

 

Three months ended
March 31, 2025

 

 

Three months ended
March 31, 2024

 

Risk-free interest rate

 

 

%

 

 

4.07

%

Expected dividend yield

 

 

 

 

 

 

Expected volatility

 

 

%

 

 

83.1

%

Expected life of options (years)

 

 

 

 

5 years

 

Grant date fair value

 

$

 

 

$

40.80

 

Schedule of Share-based Payment Award, Options, Grants in Period

The following table presents the vesting terms of options granted in the period:

 

 

 

Three months ended
March 31, 2025

 

 

Three months ended
March 31, 2024

 

 

 

Number of options

 

 

Number of options

 

3-year vesting (50%-25%-25%)

 

 

 

 

 

666

 

4-year vesting (50%-16 2/3%-16 2/3%-16 2/3%)

 

 

 

 

 

12,939

 

Total stock options granted in the period

 

 

 

 

 

13,605

 

Share-based Compensation Arrangement, Expensed and Capitalized, Amount

The Company recorded share-based compensation expense related to stock options is as follows:

 

 

 

Three months ended
March 31,

 

 

 

2025

 

 

2024

 

Research and development

 

$

141

 

 

$

328

 

General and administrative

 

 

186

 

 

 

481

 

 

 

$

326

 

 

$

809